Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
|
| Descrizione fisica: | 1 online resource (iii, 140 p.) : ill |
| Soggetto topico: | Rofecoxib - Testing |
| Nonsteroidal anti-inflammatory agents - United States - Testing | |
| Nonsteroidal anti-inflammatory agents - Safety regulations - United States | |
| Drugs - United States - Testing | |
| Drugs - Safety regulations - United States | |
| Soggetto non controllato: | Drugs |
| Medical | |
| Altri titoli varianti: | Risk and responsibility |
| Titolo autorizzato: | Risk and responsibility |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910693935903321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |